Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (1891)	5/1/1998 9:44:00 AM
From: Anthony Wong	Read Replies (2) \| Respond to of 9523

New Jersey Blue Cross Agrees to Pay for Viagra Impotence Drug Bloomberg News May 1, 1998, 5:55 a.m. PT Newark, New Jersey, May 1 (Bloomberg) -- Blue Cross/Blue Shield of New Jersey, the state's biggest health insurer, will reimburse its customers for Pfizer Inc.'s Viagra impotence drug, the Newark, New Jersey, Star-Ledger reported. Each pill costs about $10, and the publicity the drug has received as a potential way to enhance sexual performance among healthy men has led some insurers to demand proof of a pre-existing condition. New Jersey's other two large carriers, Aetna Inc.'s US Healthcare and Prudential Insurance of America's Healthcare unit, haven't decided whether to pay for the new treatment, for which prescriptions are being written at a rate of 50,000 a day, the paper said. Viagra sales could reach $1 billion in its first full year on the market, even if health plans put strict conditions on paying for the pills and men have to buy the drug themselves, analysts said this week. (Newark Star-Ledger 5/1 47 www.njnews.com) --Jennifer Farley in the Princeton newsroom (609) 279-4104 sgp